- Cello Group said it delivered an encouraging trading performance in the year to the end of December with gross profit and headline profits in line with consensus market expectations.


- Good like-for-like gross profit growth at Cello Health, with the US remaining a key growth driver.

- Strong like-for-like growth in gross profit and improved double digit operating margins by Signal.

- Excellent performance from Cello's growing suite of software-enabled products, most notably Pulsar, providing increased future gross profit visibility.

- Strong balance sheet, despite settlement of VAT liability in July, reflecting solid cash flow conversion for the period.

- Increased dividend pay-out in line with intention announced during 2016 to distribute c.40% of headline earnings.

Looking ahead, the group said it began 2017 with good momentum from existing and new clients secured in 2016 and the board was confident that current consensus market expectations would be met.

At 8:05am: [LON:CLL] Cello Group PLC share price was 0p at 100p

Story provided by